— Know what they know.
Not Investment Advice
Also trades as: VIV.V (TSXV) · $vol 0M

VIVXF OTC

Avivagen Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $7769 mcap · 77M float · 0.0002% daily turnover

Income Trends

Revenue
$939K -27.5% ▼
5Y CAGR: +29.7%
Gross Profit
$400K -25.1% ▼
5Y CAGR: +18.3%
Operating Income
-$5M -18.1% ▼
Net Income
-$6M +5.1% ▲
EPS (Diluted)
$-0.09 +23.4% ▲
EBITDA
-$4M +10.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$1M$977K$1M$1M$939K
YoY Growth+319.5%-8.9%+20.5%+10.0%-27.5%
Cost of Revenue$419K$451K$707K$762K$539K
Gross Profit$654K$526K$471K$534K$400K
Gross Margin61.0%53.9%40.0%41.2%42.6%
R&D Expenses$535K$641K$0$0$0
SG&A Expenses$4M$4M$4M$5M$2M
Operating Expenses$5M$4M$4M$5M$5M
Operating Income-$5M-$4M-$3M-$4M-$5M
Operating Margin-422.8%-420.5%-289.9%-320.0%-521.5%
Interest Expense$321K$726K$1M$2M$2M
Income Before Tax-$5M-$5M-$5M-$6M-$6M
Tax Expense$49K$676K$0$0$0
Net Income-$5M-$5M-$5M-$6M-$6M
Net Margin-450.7%-494.8%-403.4%-493.4%-645.9%
EPS (Diluted)$-0.15$-0.14$-0.12$-0.12$-0.09
EBITDA-$5M-$4M-$3M-$5M-$4M
Shares Outstanding33M34M40M52M66M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms